샘플 요청 목록

 카트 문의
시장보고서
상품코드
1651021

세계의 색전 방지 기기 시장

Embolic Protection Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

색전 방지 기기 세계 시장, 2030년까지 21억 달러에 달할 전망

2024년에 14억 달러로 추정되는 색전 방지 기기 세계 시장은 2024년부터 2030년까지 연평균 6.6%의 CAGR로 성장하여 2030년에는 21억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 원위부 필터는 CAGR 7.6%를 기록하여 분석 기간 종료 시점에 13억 달러에 도달할 것으로 예상됩니다. 근위부 폐색 부문의 성장률은 분석 기간 동안 CAGR 4.3%로 추정됩니다.

미국 시장 3억 9,990만 달러로 추정, 중국은 CAGR 6.2%로 성장 전망

미국의 색전 방지 기기 시장은 2024년에 3억 9,990만 달러에 달할 것으로 예상됩니다. 세계 2위의 경제 대국인 중국은 2024-2030년 분석 기간 동안 6.2%의 CAGR로 2030년까지 3억 2,680만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 6.3%와 5.2%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 CAGR 5.2%로 성장할 것으로 예상됩니다.

세계 색전 방지 기기 시장 - 주요 동향 및 촉진요인 정리

색전 방지 기기는 심혈관 치료에 어떤 혁명을 가져오고 있을까?

색전 방지 기기(EPD)는 경피적 관상동맥중재술(PCI) 및 경피적 대동맥판막치환술(TAVR)과 같은 시술의 안전성과 유효성을 크게 향상시킴으로써 심혈관 치료에 혁명을 일으키고 있습니다. 이 장치들은 이러한 시술 중 발생할 수 있는 혈전 조각을 포착하고 제거하여 혈전 조각이 혈류로 이동하여 뇌졸중, 심근경색, 장기 손상과 같은 합병증을 유발하는 것을 방지하도록 특별히 고안된 장치입니다. 이를 통해 EPD는 심혈관계 시술의 주요 위험 요소 중 하나인 색전증, 특히 색전증에 취약한 고위험군 환자의 위험을 줄일 수 있습니다. 이러한 장비의 도입은 시술 합병증 발생률을 낮춤으로써 환자의 결과를 개선하고 복잡한 심혈관계 치료를 보다 안전하고 효과적으로 만들어 줍니다. 전 세계적으로 심혈관질환의 부담이 계속 증가함에 따라 환자의 안전을 보장하고 시술의 성공률을 높이는 색전 방지 기기의 역할은 현대 심혈관 치료에서 점점 더 중요해지고 있습니다.

색전 방지 기기의 기능성을 높이는 혁신이란?

색전 방지 기기의 혁신은 디자인, 재료, 다른 심혈관 기술과의 통합의 진보를 통해 그 기능을 향상시키고 있습니다. 가장 중요한 발전 중 하나는 이러한 장치의 소형화로, 더 작은 혈관에 더 높은 정확도와 최소의 파괴로 배치할 수 있게 되었습니다. 이는 경동맥 스텐트 삽입술과 같이 뇌졸중 위험이 높고 정확한 삽입이 중요한 시술에서 특히 중요합니다. 또한, 생체적합성 폴리머와 미세한 메시 필터와 같은 첨단 소재의 사용으로 혈류를 방해하지 않고 가장 작은 색전물 입자까지 포착할 수 있는 EPD의 능력이 향상되었습니다. 이를 통해 합병증 위험을 줄이고 회복 시간을 개선하며 보다 효과적이고 환자 친화적인 장치를 개발할 수 있게 되었습니다. 또한, 색전 방지 기기와 혈관내 초음파(IVUS) 및 광학 간섭 단층 촬영(OCT)과 같은 영상 기술과의 통합을 통해 시술 중 실시간 시각화가 가능해졌습니다. 이러한 통합을 통해 임상의는 EPD의 정확한 위치를 파악하고 성능을 모니터링하여 색전증 발생에 대한 최적의 보호를 보장할 수 있습니다. 이러한 혁신을 통해 색전 방지 기기는 보다 효율적이고, 사용하기 쉽고, 안전하며, 광범위한 심혈관 중재시술에서 그 역할이 더욱 강화되고 있습니다.

색전 방지 기기는 환자의 치료 결과와 시술 안전에 어떤 영향을 미치는가?

색전 방지 기기는 심혈관 중재시술 중 혈전 합병증의 위험을 크게 감소시켜 환자의 결과와 시술의 안전성에 큰 영향을 미칩니다. 경동맥 스텐트삽입술, TAVR, PCI와 같은 시술에서 플라크나 혈전이 떨어지면 뇌졸중이나 심장마비 등 심각한 합병증을 유발할 수 있습니다. 뇌나 관상동맥과 같은 중요한 부위로 이동하기 전에 이 파편을 포착함으로써 EPD는 이러한 부작용의 발생률을 극적으로 감소시킵니다. 이러한 안전성 프로파일의 개선은 환자의 예후를 개선할 뿐만 아니라, 기존에 고위험군으로 간주되었던 환자들을 포함하여 최소침습적 심혈관계 시술의 대상 환자군을 확대할 수 있습니다. 또한, EPD를 사용하면 환자가 겪는 합병증이 적고, 수술 후 집중 치료를 덜 받아야 하기 때문에 입원 기간이 단축되고 회복 시간이 단축됩니다. 의료 서비스 제공자에게는 시술의 위험과 관련 합병증 감소는 전반적인 성공률 향상과 잠재적인 의료비 절감으로 이어집니다. 색전 방지 기기는 심혈관 치료에서 가장 심각한 위험 중 하나를 피함으로써 환자 치료를 개선하고 생명을 구하는 시술의 안전성을 향상시키는 데 중요한 역할을 합니다.

색전 방지 기기 시장의 성장을 촉진하는 트렌드는 무엇인가?

심혈관질환의 유병률 증가, 최소침습적 시술의 확대, 의료 기술의 지속적인 발전 등이 색전 방지 기기 시장의 성장을 주도하고 있습니다. 죽상동맥경화증, 심장판막증, 경동맥 협착증 등의 유병률 증가는 심혈관 중재시술의 증가로 이어져 EPD에 대한 수요를 증가시키고 있습니다. 전 세계 인구가 고령화되고 심혈관질환의 부담이 증가함에 따라 안전하고 효과적인 치료 옵션의 필요성이 점점 더 중요해지고 있으며, TAVR 및 경동맥 스텐트 삽입술과 같은 최소침습적 시술로의 전환도 시장 성장에 박차를 가하고 있습니다. 이러한 시술은 일반적으로 색전증 발생 위험이 높기 때문에 환자의 안전을 보장하기 위해 EPD가 필수적입니다. 또한, 여과 기능이 강화되고 전달 시스템이 개선된 차세대 EPD의 개발 등 기기 설계의 지속적인 발전으로 인해 EPD의 용도와 효능이 확대되고 있으며, EPD의 이점에 대한 규제 당국의 승인과 의료진의 인식이 높아짐에 따라 시장 확대에 더욱 기여하고 있습니다. 이러한 추세는 심혈관 의료 분야에서 EPD가 중요한 개입의 안전성과 성공률을 높이는 데 있어 매우 중요한 역할을 하고 있으며, 심혈관 의료 분야에서 그 중요성이 점점 더 커지고 있음을 입증하고 있습니다.

부문

유형(원위부 필터, 근위부 폐색, 원위부 폐색), 적용 분야(심혈관질환, 말초혈관질환, 신경혈관질환)

조사 대상 기업 사례(주목 42개사)

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.02.21

Global Embolic Protection Devices Market to Reach US$2.1 Billion by 2030

The global market for Embolic Protection Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Distal Filter, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Proximal Occlusion segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$399.9 Million While China is Forecast to Grow at 6.2% CAGR

The Embolic Protection Devices market in the U.S. is estimated at US$399.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$326.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Embolic Protection Devices Market - Key Trends and Drivers Summarized

How Are Embolic Protection Devices Revolutionizing Cardiovascular Care?

Embolic protection devices (EPDs) are revolutionizing cardiovascular care by significantly enhancing the safety and efficacy of procedures like percutaneous coronary interventions (PCI) and transcatheter aortic valve replacements (TAVR). These devices are specifically designed to capture and remove embolic debris that may dislodge during these interventions, preventing it from traveling through the bloodstream and causing complications such as stroke, myocardial infarction, or organ damage. By doing so, EPDs mitigate one of the major risks associated with cardiovascular procedures, particularly in high-risk patients who are more susceptible to embolic events. The introduction of these devices has improved patient outcomes by reducing the incidence of procedural complications, thereby making complex cardiovascular treatments safer and more effective. As the global burden of cardiovascular disease continues to rise, the role of embolic protection devices in ensuring patient safety and enhancing procedural success is becoming increasingly important in modern cardiovascular care.

What Innovations Are Enhancing the Functionality of Embolic Protection Devices?

Innovations in embolic protection devices are enhancing their functionality through advancements in design, materials, and integration with other cardiovascular technologies. One of the most significant developments is the miniaturization of these devices, allowing them to be deployed in smaller blood vessels with greater precision and minimal disruption. This is particularly important in procedures like carotid artery stenting, where the risk of stroke is high and precise placement is crucial. Additionally, the use of advanced materials, such as biocompatible polymers and fine mesh filters, has improved the ability of EPDs to capture even the smallest embolic particles without impeding blood flow. This has led to the development of more effective and patient-friendly devices that reduce the risk of complications and improve recovery times. Furthermore, the integration of embolic protection devices with imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is enabling real-time visualization during procedures. This integration allows clinicians to accurately position EPDs and monitor their performance, ensuring optimal protection against embolic events. These innovations are making embolic protection devices more efficient, easier to use, and safer, enhancing their role in a wide range of cardiovascular interventions.

How Do Embolic Protection Devices Impact Patient Outcomes and Procedure Safety?

Embolic protection devices have a profound impact on patient outcomes and procedure safety by significantly reducing the risk of embolic complications during cardiovascular interventions. In procedures such as carotid artery stenting, TAVR, and PCI, the dislodgement of plaque or thrombus can lead to serious complications, including stroke or heart attack. By capturing this debris before it can travel to critical areas like the brain or coronary arteries, EPDs dramatically reduce the incidence of these adverse events. This improved safety profile not only enhances patient outcomes but also expands the pool of patients eligible for minimally invasive cardiovascular procedures, including those who were previously considered high-risk. Moreover, the use of EPDs can lead to shorter hospital stays and quicker recovery times, as patients experience fewer complications and require less intensive postoperative care. For healthcare providers, the reduction in procedural risks and associated complications translates into better overall success rates and potentially lower healthcare costs. By safeguarding against one of the most significant risks in cardiovascular interventions, embolic protection devices are playing a critical role in advancing patient care and improving the safety of life-saving procedures.

What Trends Are Driving Growth in the Embolic Protection Devices Market?

Several trends are driving growth in the embolic protection devices market, including the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and the continuous advancements in medical technology. The rising incidence of conditions such as atherosclerosis, heart valve diseases, and carotid artery stenosis is leading to an increase in the number of cardiovascular interventions, thereby boosting demand for EPDs. As the global population ages and the burden of cardiovascular diseases grows, the need for safe and effective treatment options is becoming more critical. The shift towards minimally invasive procedures, such as TAVR and carotid artery stenting, is also fueling market growth, as these procedures typically carry a higher risk of embolic events, making EPDs essential for ensuring patient safety. Moreover, ongoing advancements in device design, including the development of next-generation EPDs with enhanced filtration capabilities and improved delivery systems, are expanding the applications and effectiveness of these devices. Regulatory approvals and increasing awareness among healthcare providers about the benefits of EPDs are further contributing to market expansion. These trends underscore the growing importance of embolic protection devices in the field of cardiovascular medicine, as they continue to play a pivotal role in enhancing the safety and success of critical interventions.

SCOPE OF STUDY:

The report analyzes the Embolic Protection Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Distal Filter, Proximal Occlusion, Distal Occlusion); Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Neurovascular Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Embolic Protection Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Embolic Protection Devices
    • Increasing Adoption of Minimally Invasive Surgical Techniques Bolsters Market Growth
    • Rising Global Health Awareness and Healthcare Access Enhancing Market Opportunities
    • Economic Factors Influencing Healthcare Spending and Device Adoption
    • Development of Next-Generation Embolic Protection Devices for Neurovascular Applications
    • Increasing Incidence of Atrial Fibrillation and Stroke Risk Management
    • Market Influence of Aging Populations on Cardiovascular Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Distal Filter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Distal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Proximal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Peripheral Vascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Neurovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Embolic Protection Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제